InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Insider track record
CEODisclosed buys
0
Disclosed sells
5
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the detailed record of transactions filed by CHALMERS DEREK T, Chief Executive Officer. Insider active across 1 company, notably Cara Therapeutics, Inc.. Cumulatively, 7 reports have been logged. Breakdown: 0 buy · 5 sells. Total volume traded: €726k. History available since 24 August 2021. The latest transaction was disclosed on 7 September 2021 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations7 total
20,000 shares@ US$15.4736.0% of flowCommon StockSEC:0001209191-21-055304:0
20,000 shares@ US$15.4736.0% of flowCommon StockSEC:0001209191-21-055304
8,440 shares@ US$14.2014.0% of flowCommon StockSEC:0001209191-21-054300:0
8,440 shares@ US$14.2014.0% of flowCommon StockSEC:0001209191-21-054300
17,334 shares0Common StockSEC:0001209191-21-053534:0
17,334 shares0Common StockSEC:0001209191-21-053534
12,500 sharesCommon StockSEC:0001209191-16-090440:0
7 of 7 declarations
About CHALMERS DEREK T
Derek T. Chalmers is the President and CEO of Cara Therapeutics, Inc. He oversees the company's operations and is responsible for implementing the business strategy. Derek plays a crucial role in leading the company and making strategic decisions. His leadership is essential for ensuring Cara Therapeutics' growth and success.
